Another interesting finding from multiple studies is that PD-L1 is a direct transcription target of YAP, and thus, YAP activation could upregulate PD-L1 expression and promote tumor immune escape in NSCLC, mesothelioma, and melanoma. The gene discussed is CD274; the disease is non-small cell lung carcinoma.